e3cb1134-e848-4b4b-9100-f68364b71f6b.pdf (651.7 KB)
The plaintiffs voluntarily dismissed Breckenridge Pharmaceutical Inc. and Natco Pharma Limited from the case. All claims against the Company in the litigation have now been dismissed in the antitrust lawsuit in US.
Job well done!
Posts tagged Value Pickr
Natco Pharma: Focusing On Complex Products (21-12-2023)
Gravita India success story (21-12-2023)
They are just putting up a pilot plant to test feasibility of Li-Ion recycling. Based on the success of this pilot, they may go for a larger commercial plant. I think this is a good move, albeit cautiously, to be future ready.
Mrs Bectors Food Specialities: Can it beat the industry? (21-12-2023)
Thanks for sharing such valuable information!
Steel pipes industry – big growth expected? (21-12-2023)
It’s been almost five years since I made this post. Here’s an update of the market cap of the pipe companies since then.
-
RMG Alloy Steel has been renamed as Welspun Specialty Solutions Ltd.
-
Rs.5000 invested in each of these stocks would be an investment of Rs.1,00,000. This would be worth at least Rs.7,50,000. I’ve ignored the merged and de-listed stocks for calculation although the merged stocks would have value. This is an over 40% annualized return pre-tax. The S&P BSE 250 SmallCap Index was 2038.98 on February 22, 2019. It is 5,498.97 today and Rs.100,000 invested in it would have been worth close to Rs.270,000 today. It seems that if one expects an industry to do well, it’s good to buy a basket of stocks from the industry and hold for long term.
TARSONS products ltd (21-12-2023)
Interesting development here.
Tarsons has acquired 100% stake in Nerbe R&D GmbH and Nerbe plus GmbH & Co (German Company in similar line of business, i.e., distribution of plastic labware) for a consideration of ~15 million Euros, roughly 136 Crores INR. (Assuming higher end of band mentioned in disclosure, ie. 10-15 Euros).
This acquisition is done via Tarson’s subsidiary, Tarsons Life Science Pte Ltd. and Nerbe will be a 100% step-down subsidiary of Tarsons after the closure of deal.
Interestingly Nerbe GmbH is a profitable company with 4.9 Million Euros EBITDA and 16 Million Euros of topline in FY 22, earlier years were better in terms of profitability. (Seems a distress acquisition)
Disclosure: Holding.
SmallCap Hunter : Trying to find the dark horses with triggers (21-12-2023)
Pls discuss about Spels. It is good or bad for us.
Red Tape Ltd. – The next fashion giant? (21-12-2023)
Hi guys the September Quarter results were nothing great, what is the expectations for this quarter? … the stock has started cracking from peak of 550 down to 445.
Great articles to read on the web (21-12-2023)
Over the last 60 years, a lot of R&D has gone to bring the cost of compute down to near zero. This led to a personal device in every hand. We also have had the cost of distributing this compute down to near zero as well. That brought the marginal cost of software down to zero, which is basically the reason the internet exists. The next 30 years is going to bring the cost of intelligence down to zero.Capex & Opex supercycles — the dusk of SaaS and the dawn of AI-SaaS | by Hemant Mohapatra | Dec, 2023 | Medium
Sky Gold ltd. – Will it reach the sky? (21-12-2023)
Hi Mohit, I agree that the standalone and consolidated is the same. I am talking about CFO and not CFI. I would be very interested in the stock if the CFO was positive, which I don’t see as per screener. How are their investments a reflection of the negative CFO of the past few years?